Raphael Warnock (D-GA)

Capping Prescription Costs Act of 2025

S. 529 · Senate bill Health

A Democratic bill with 13 Democratic cosponsors · See all 13 cosponsors

Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Capping Prescription Costs Act of 2025 aims to limit the amount people have to pay out-of-pocket for prescription drugs. Under this bill, cost-sharing for prescription drugs covered by a health plan would be capped at $2,000 per year for individuals and $4,000 per year for families starting in 2026. For years after 2026, these limits would be adjusted annually based on the medical care component of the consumer price index. These limits would apply to Qualified Health Plans, as well as Group Health Plans. The changes are set to take effect for plan years beginning on or after January 1, 2026.

Yes· 3 of 8

  • Scored +7

    Does this lower the price of prescription medicines?

    The bill limits out-of-pocket cost-sharing for prescription drugs to $2,000 for individuals and $4,000 for families.

  • Scored +6

    Would households on low incomes be better off under this?

    The cap on prescription drug spending helps protect low-income households from high medical costs.

  • Scored +5

    Would people over 65 be better off under this?

    Capping prescription drug costs provides significant financial protection for seniors on fixed incomes.

The opposite

No question was scored the opposite.